CTNM   $12.11  -0.90% Market Closed After Close 12.11 0.0

Contineum Therapeutics, Inc.
Total Cash 218.65M
totalCashPerShare 8.5
EBITDA -38.42M
Total Debt 597.00K
quickRatio 58.479
currentRatio 58.925
Total Revenue 0.00
debtToEquity 0.274
Revenue/Share 0.0
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -32.55M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 210.24M
forwardPE -9.514285
floatShares 12.69M
sharesOutstanding 18.99M
sharesShort 952.35K
sharesShortPriorMonth 813.70K
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.11%
heldPercentInstitutions 0.69%
Short Ratio help_outline 15.66%
shortPercentOfFloat
impliedSharesOutstanding
bookValue 8.455
Price To Book help_outline 1.97
earningsQuarterlyGrowth
netIncomeToCommon -19.80M
trailingEps -0.01%
forwardEps -1.75%
enterpriseToEbitda -5.47
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.41 3Q 2024
institutionsCount 78
lastUpdated Nov. 2, 2024, 7:18 a.m.